Accelerating research translation

Our Vision

Substantiate Fragment Based Design as a highly valuable strategy for identifying novel ligands for a range of protein targets.


Headquartered at Monash Institute of Pharmaceutical Sciences, the ARC CFBD brings together key academic institutions and their state-of the art infrastructure; Monash Fragment Platform, Griffith University Institute for Drug Discovery, The University of Sydney Drug Discovery Initiative, with industry research partners who have clear pathways for research translation.